<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02116751</url>
  </required_header>
  <id_info>
    <org_study_id>EC 039/14</org_study_id>
    <nct_id>NCT02116751</nct_id>
  </id_info>
  <brief_title>Frequency and Clinical Significance of Renal and Bone Toxicity in HIV-infected Patients</brief_title>
  <acronym>ComorVIH</acronym>
  <official_title>Frequency and Clinical Significance of Renal and Bone Toxicity in HIV-infected Patients: Role of Classical Factors, HIV Infection, and Antiretroviral Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asociacion para el Estudio de las Enfermedades Infecciosas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Asociacion para el Estudio de las Enfermedades Infecciosas</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the frequency of renal and bone toxicity in HIV
      infected patients receiving antiretroviral therapy, and the outcome in terms of treatment
      change or/and virological failure, in relation with the presence of classical factors, such
      as diabetes or hypertension, the role of HIV itself, because of chronic inflammation, and the
      effects of antiretroviral medication.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a retrospective cohort study involving 300 patients to determine the frequency of
      renal and bone comorbidities/toxicity in a large population of HIV-infected patients
      receiving antiretroviral therapy, in order to establish the differential role of classical
      factors, HIV infection, or antiretroviral therapy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Renal and Bone toxicity</measure>
    <time_frame>Patients will be evaluated for 2 years before</time_frame>
    <description>Number and percentage of patients with:
Confirmed estimated glomerular filtration rate (eGFR) by CKD (chronic kidney disease)-epi equation decrease to &lt; 60 ml/min, or/and
More than 25% of eGFR decrease during therapy, or/and
Tubular toxicity defined as at least two of confirmed proteinuria (&gt; 300 mg/g), glycosuria with euglycemia, fractional excretion of urinary phosphate &gt; 20%, or of uric acid &gt; 10%. AND
Number and percentage of patients with bone mineral density (BMD) decrease &gt; 10% during follow up or progression to osteopenia (from normal) or to osteoporosis (from osteopenia)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Consequences of renal or bone toxicity</measure>
    <time_frame>Patients will be evaluated for 2 years before</time_frame>
    <description>Percentage of patients with regimen discontinuation (any drug in the regimen) because of renal or/and bone toxicity</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Changes in renal and bone toxicity</measure>
    <time_frame>2 years before entry</time_frame>
    <description>Evolution of renal and bone parameters in case of regimen discontinuation</description>
  </other_outcome>
  <enrollment type="Actual">306</enrollment>
  <condition>Renal Toxicity</condition>
  <eligibility>
    <study_pop>
      <textblock>
        HIV infected patients in active follow up, receiving antiretroviral therapy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Confirmed HIV infection

        Exclusion Criteria:

          -  Pregnancy

          -  Prior therapy with antineoplastic chemotherapy or chronic treatment with
             corticosteroids

          -  Previous chronic therapy with antiresorptive bone therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jose L Casado, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ramon y Cajal Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ramon y Cajal Hospital</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 11, 2014</study_first_submitted>
  <study_first_submitted_qc>April 15, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 17, 2014</study_first_posted>
  <last_update_submitted>December 6, 2014</last_update_submitted>
  <last_update_submitted_qc>December 6, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 9, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HIV, antiretroviral, toxicity, eGFR, tubular disease, BMD</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

